|
|||
2010-12-21 08:00:00 CET 2010-12-21 08:00:45 CET REGULATED INFORMATION Oriola-KD Oyj - Company AnnouncementOriola-KD's revised guidelines on net sales and operating profit for 2010Oriola-KD Corporation Stock Exchange Release 21 December 2010 at 9.00 a.m. Guidelines issued on 28 October 2010 Oriola-KD's net sales from its continuing operations for 2010 are expected to be higher than in 2009 and operating profit is forecasted to be clearly lower than in 2009. The operating result of Pharmaceutical Trade Russia, including the recognised one-off costs in the third quarter, is expected to be negative. Revised guidelines issued on 21 December 2010 Oriola-KD's net sales from continuing operations, excluding Healthcare and Dental Trade businesses, is expected to be some EUR 1.9 billion and operating profit, excluding one-off costs, is expected to be some EUR 20 million in 2010. One-off costs are expected to be in total some EUR 13 million in 2010, including a provision related to the restructuring of Oriola-KD's Swedish Pharmaceutical Wholesale operations in the fourth quarter of 2010. Oriola-KD's operating profit for 2010 for continued and discontinued operations, gain on sales of assets and one-off costs is expected to be some EUR 106 million. The operating loss of Pharmaceutical Wholesale Russia decreases significantly Oriola-KD's operating profit in 2010. Operations in Sweden and Finland have developed according to plan. Oriola-KD Corporation Eero Hautaniemi President and CEO Kimmo Virtanen Executive Vice President and CFO Further information: Kimmo Virtanen Executive Vice President and CFO tel. +358 (0)10 429 2069 e-mail: kimmo.virtanen@oriola-kd.com Pellervo Hämäläinen Vice President, Communications and Investor Relations tel. +358 (0)10 429 2497 e-mail: pellervo.hamalainen@oriola-kd.com Distribution NASDAQ OMX Helsinki Ltd Principal media Published by: Oriola-KD Corporation Corporate Communications Orionintie 5 FI-02200 Espoo, Finland www.oriola-kd.com [HUG#1474366] |
|||
|